3/A

Filing

RenovoRx, Inc. Filed 2022-06-17 Acc 0001493152-22-017152

Documents 1

3/A , xslF345X02/ownership.xml

Around this filing

2026-03-27 3/A 3/A
2022-06-17 4 Chief Medical Officer acquired 1,295 shares (conversion)
2022-06-17 3/A 3/A

Link to a passage

External

SEC EDGAR (opens in new tab)